Publications by authors named "Toby Simon"

Claim this Profile
C
Consistent supply of global plasma for global patients.
Michelle Fransen, Toby Simon, James Knowles, Joshua Penrod

Vox Sang· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why do US source plasma donors stop donating?
Michelle Fransen, Mark Becker, Janet Hershman, James Lenart, Toby L Simon

Transfusion· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of donation frequency on U.S. source plasma donor health.
Michelle Fransen, Mark Becker, Janet Hershman, James Lenart, Toby Simon

Transfusion· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective, open-label, multicenter clinical study to assess the performance of a new donation system for the collection of source plasma.
Emily Mason, Kati Dawson, Jack Rhodes, James Kelley, Erin Goodhue Meyer, Toby L Simon

J Clin Apher· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review and assessment of the donor safety among plasma donors.
Mitali Purohit, Mel Berger, Rachpal Malhotra, Toby Simon

Transfusion· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperoncotic human albumin solutions for intravenous fluid therapy: Effectiveness of pathogen safety and purification methods, and clinical safety.
Toby Simon, Philipp Schumann, Michael Bieri, Kathrin Schirner, Eleonora Widmer

Biosaf Health· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of 52 240 source plasma donors of convalescent COVID-19 plasma: Sex, ethnicity, and age association with initial antibody levels and rate of dissipation.
Amy E Schmidt, Peter Vogel, Carrie A Chastain, Thomas Barnes, Nathan J Roth, Toby L Simon

J Clin Apher· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Source plasma deferral trends: A 3-year analysis of 255 centers in the United States.
Amy E Schmidt, Jaime MacKercher, Barbara Youngling, Toby L Simon

J Clin Apher· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of neutralising anti-SARS-CoV-2 antibody half-life in COVID-19 convalescent donors.
Thomas W Barnes, Johannes Schulte-Pelkum, Laura Steller, Daniel Filchtinski, Robin Jenness, Toby L Simon

Clin Immunol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis A Virus Incidence Rates and Biomarker Dynamics for Plasma Donors, United States.
Stephanie Schoch, Martin Wälti, Mathias Schemmerer, Rick Alexander, Björn Keiner, Toby Simon

Emerg Infect Dis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasmavigilance-Adverse events among US Source plasma donors.
George B Schreiber, Mark Becker, Michelle Fransen, Janet Hershman, James Lenart, Toby Simon

Transfusion· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-A/B isoagglutinin reduction in an intravenous immunoglobulin product and risk of hemolytic anemia: a hospital-based cohort study.
Christopher Wallenhorst, Ami Patel, Amgad Shebl, Alphonse Hubsch, Toby L Simon

Transfusion· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Manufacturing of plasma-derived C1-inhibitor concentrate for treatment of patients with hereditary angioedema.
Toby L Simon, Uwe Kalina, Reiner Laske, Sarah Mycroft, Eleonora Widmer

Allergy Asthma Proc· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal changes in measles antibody titers in plasma donors and minimum antibody levels of immunoglobulin products for treatment of primary immunodeficiency.
Toby L Simon, Peter FitzGerald, Mirjam Kühne, Connie Farrar, Jonathan Knowles

Transfusion· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequent source plasma donors are not at risk of iron depletion: the Ferritin Levels in Plasma Donor (FLIPD) study.
George B Schreiber, Roger Brinser, Marilyn Rosa-Bray, Zi-Fan Yu, Toby Simon

Transfusion· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity and specificity of a new automated system for the detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus nucleic acid in blood and plasma donations.
Susan A Galel, Toby L Simon, Phillip C Williamson, James P AuBuchon, Dan A Waxman

Transfusion· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of screening and exclusion of high anti-A titer donors on the risk of hemolytic anemia with intravenous immunoglobulin treatment: A hospital-based cohort study in the US.
Carlos Martinez, Douglas J Watson, Amgad Shebl, Christopher Wallenhorst, Alphonse Hubsch, Toby L Simon

Am J Hematol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low hepatitis E virus RNA prevalence in a large-scale survey of United States source plasma donors.
Nathan J Roth, Wolfram Schäfer, Rick Alexander, Kevin Elliott, Wlenyeno Elliott-Browne, Toby L Simon

Transfusion· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measles Virus Neutralizing Antibodies in Intravenous Immunoglobulins: Is an Increase by Revaccination of Plasma Donors Possible?
Jens Modrof, Björn Tille, Maria R Farcet, John McVey, Jessica A Schreiner, Toby L Simon

J Infect Dis· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of a pasteurized plasma-derived Factor VIII and von Willebrand factor concentrate: analysis of 33 years of pharmacovigilance data.
Peter Kouides, Kathrin Wawra-Hehenberger, Anna Sajan, Henry Mead, Toby Simon

Transfusion· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on Stotler BA, Schwartz J. How we use WinRho in patients with idiopathic thrombocytopenic purpura. Transfusion 2015:55:2547-50.: This article is a comment on Stotler and Schwartz [2015] DOI: 10.1111/trf.13185.
Toby L Simon

Transfusion· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogen inactivation and removal methods for plasma-derived clotting factor concentrates.
Robert Klamroth, Albrecht Gröner, Toby L Simon

Transfusion· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laboratory variables for assessing iron deficiency in REDS-II Iron Status Evaluation (RISE) blood donors.
Joseph E Kiss, Whitney R Steele, David J Wright, Alan E Mast, Patricia M Carey, Toby L Simon

Transfusion· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population-based screening for anemia using first-time blood donors.
Alan E Mast, Whitney R Steele, Bryce Johnson, David J Wright, Ritchard G Cable, Toby L Simon

Am J Hematol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron deficiency in blood donors: the REDS-II Donor Iron Status Evaluation (RISE) study.
Ritchard G Cable, Simone A Glynn, Joseph E Kiss, Alan E Mast, Whitney R Steele, Toby L Simon

Transfusion· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis